Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
160.3 USD | -0.07% | -0.20% | +3.57% |
09:44am | Medincell: share price rises on resumption of trading | CF |
May. 08 | AbbVie Says Canadian Regulator Expands Qulipta Indication to Cover Chronic Migraine | MT |
Financials (USD)
Sales 2024 * | 54.95B | Sales 2025 * | 57.98B | Capitalization | 283B |
---|---|---|---|---|---|
Net income 2024 * | 7.99B | Net income 2025 * | 10.88B | EV / Sales 2024 * | 6.13 x |
Net Debt 2024 * | 53.44B | Net Debt 2025 * | 47.17B | EV / Sales 2025 * | 5.7 x |
P/E ratio 2024 * |
31.2
x | P/E ratio 2025 * |
23.9
x | Employees | 50,000 |
Yield 2024 * |
3.85% | Yield 2025 * |
4.05% | Free-Float | 96.37% |
Latest transcript on AbbVie Inc.
1 day | -1.29% | ||
1 week | -0.79% | ||
Current month | -1.35% | ||
1 month | -5.51% | ||
3 months | -8.20% | ||
6 months | +12.97% | ||
Current year | +3.54% |
Managers | Title | Age | Since |
---|---|---|---|
Richard Gonzalez
CEO | Chief Executive Officer | 70 | 12-12-31 |
Scott Reents
DFI | Director of Finance/CFO | 57 | 12-12-31 |
Robert Michael
PSD | President | 53 | 11-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Roxanne Austin
BRD | Director/Board Member | 63 | 12-12-31 |
Edward Rapp
BRD | Director/Board Member | 66 | 12-12-31 |
Director/Board Member | 70 | 12-12-31 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
7.12% | 0 M€ | 0.00% | - | |
6.85% | 0 M€ | +5.54% | - | |
6.26% | 13 M€ | -.--% |
Date | Price | Change | Volume |
---|---|---|---|
24-05-09 | 160.5 | +0.01% | 1 412 263 |
24-05-08 | 160.4 | -1.29% | 5,906,701 |
24-05-07 | 162.6 | -0.11% | 5,301,668 |
24-05-06 | 162.7 | -0.65% | 5,834,562 |
24-05-03 | 163.8 | +1.85% | 5,850,102 |
Delayed Quote Nyse, May 08, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+3.54% | 283B | |
+32.95% | 698B | |
+26.51% | 568B | |
-4.97% | 358B | |
+18.83% | 328B | |
+15.62% | 238B | |
+6.68% | 203B | |
-9.08% | 198B | |
+6.70% | 165B | |
-1.81% | 160B |
- Stock Market
- Equities
- ABBV Stock